
    
      Subjects meeting criteria for Social Anxiety Disorder, will receive enteric-coated,
      eicosapentaenoic acid-concentrated fish oil (O3mega+Joy) for 12 weeks of treatment for social
      phobia. A secondary objective is to determine if treatment outcome is related to changes in
      plasma phospholipid essential fatty acid status, niacin skin flush and measures of
      lipid/protein change.
    
  